Related Experiment Video
Updated: Jun 12, 2026
Imaging Cleared Embryonic and Postnatal Hearts at Single-cell Resolution
Published on: October 7, 2016
Identification of the heart as the critical site of adenosine mediated embryo protection
Christopher C Wendler1, Ryan R Poulsen, Satish Ghatpande
1Department of Pediatrics, Section of Developmental Endocrinology and Biology, Yale Child Health Research Center, Yale University School of Medicine, New Haven, CT 06520 USA. christopher.wendler@yale.edu
Insights
Adenosine protects developing embryos from hypoxia by acting through adenosine A1 receptors (A1ARs) in the heart. Deleting these receptors in the embryonic heart significantly reduced embryo survival during hypoxic stress.
Area of Science:
- Developmental Biology
- Cardiovascular Physiology
- Molecular Genetics
Background:
- Embryonic development relies on protective mechanisms against intrauterine stress, such as hypoxia.
- Adenosine signaling via adenosine A1 receptors (A1ARs) is known to protect embryos from hypoxia.
- The specific sites of A1AR action mediating this protection remain unidentified.
Purpose of the Study:
- To investigate whether the embryonic heart is a critical site for adenosine-mediated protection against hypoxia.
- To determine the role of cardiac A1ARs in embryonic survival under hypoxic conditions.
Main Methods:
- Selective deletion of A1ARs in cardiomyocytes using a Cre-LoxP system driven by the alpha-myosin heavy chain promoter.
- Exposure of pregnant dams and their embryos to varying durations of maternal hypoxia (10% O2) starting at embryonic day 8.5.
- Assessment of embryo viability, cardiac size, and gene expression.
Main Results:
- Cardiac-specific deletion of A1ARs significantly decreased embryo viability under prolonged hypoxia (72-96 hours).
- Hypoxia exposure from embryonic day 10.5-12.5 led to a 49% reduction in viability in affected embryos.
- Reduced cardiac size and altered gene expression patterns were observed in embryos lacking cardiac A1ARs during hypoxia.
Conclusions:
- The embryonic heart is identified as a critical site for adenosine-mediated protection against hypoxia.
- These findings reveal a novel mechanism of embryo protection involving cardiac adenosine signaling.
Background:
Our understanding of the mechanisms that protect the developing embryo from intrauterine stress is limited. Recently, adenosine has been demonstrated to play a critical role in protecting the embryo against hypoxia via adenosine A1 receptors (A1ARs), which are expressed in the heart, nervous system, and other sites during development. However, the sites of A1AR action that mediate embryo protection are not known. To determine if the heart is a key site of adenosine-mediated embryo protection, A1ARs were selectively deleted in the embryonic heart using a Cre-LoxP system in which the alpha-myosin heavy chain promoter drives Cre-recombinase expression and excision of the A1AR gene from cardiomyocytes.
Results:
With increasing exposure of maternal hypoxia (10% O2) from 48-96 hours beginning at embryonic day (E) 8.5, embryo viability decreased in the cardiac-A1AR deleted embryos. 48 hours of hypoxia reduced embryonic viability by 49% in embryos exposed from E10.5-12.5 but no effect on viability was observed in younger embryos exposed to hypoxia from E8.5-10.5. After 72 hours of hypoxia, 57.8% of the cardiac-A1AR deleted embryos were either dead or re-absorbed compared to 13.7% of control littermates and after 96 hours 81.6% of cardiac-A1AR deleted embryos were dead or re-absorbed. After 72 hours of hypoxia, cardiac size was reduced significantly more in the cardiac-A1AR deleted hearts compared to controls. Gene expression analysis revealed clusters of genes that are regulated by both hypoxia and A1AR expression.
Conclusions:
These data identify the embryonic heart as the critical site where adenosine acts to protect the embryo against hypoxia. As such these studies identify a previously unrecognized mechanism of embryo protection.
